JB Chemicals & Pharmaceuticals announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Amitriptyline Hydrochloride Tablets USP.
The approved dosages10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mgare indicated for the treatment of symptoms of depression. Amitriptyline Hydrochloride is a tricyclic antidepressant widely prescribed for managing major depressive disorders.JB Chemicals & Pharmaceuticals manufactures a wide range of pharmaceutical formulation specialties, radio-diagnostics, APIs, and intermediates.
The company's consolidated net profit rose 15.5% to Rs 145.69 crore on a 10.2% rise in revenue to Rs 949.48 crore in Q4 FY25, compared with Q4 FY24.
Shares of JB Chemicals & Pharmaceuticals rose 0.10% to Rs 1,800.60 on the BSE.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content